Gastrointestinal abnormalities are common in chronic renal failure and may affect the entire length of the gastrointestinal tract. They vary from mild edema, inflammation, and erosions to frank ulcerations and necrosis (1) . The present review focuses on the gastroduodenal consequences of uremia.
The effect of uremia on gastric acid production is uncertain. Some Investigators have reported increased basal and nocturnal acid secretion, and augmented responses to pentagastrin stimulation. This has been correlated with the presence of gastritis or peptic ulcer disease (2) (3) (4) . Other Authors, however, have found normal acid secretion (5-7) or even reduced basal and stimulated acid output or achlorhydria (4, 8, 9) . Also uncertain is the effect of controlling uremia on gastric acid production. Compared to patients with chronic renal failure given conservative therapy, hemodialysis and transplantion patients seem to have increased gastric acid output (6, 8, 10) . This is often associated with an increased incidence of upper gastrointestinal lesions, especially in kidney transplant recipients. Although it is difficult to be certain, patients with higher basal or stimulated gastric acid output appear to be at a greater risk of developing gastroduodenal complications (8) .
Gastrin, a potent stimulant of gastric acid secretion by parietal cells, is mostly increased in end stage renal disease. It is a polypeptide produced by G-cells of the antrum that is found in two major circulating forms, big gastrin (G34) and little gastrin (G17). Normally, G17 is the more abundant and active of the two peptides. As G34 is primarily cleared by the kidney, it can rise in the presence of renal failure. Although earlier reports implicated elevated gastrin levels as a cause of increased acid output and peptic ulceration these observations have not been substantiated. In fact most studies have shown either little or no direct correlation (4) or an inverse correlation between gastrin levels and acid production (9) (10) (11) . This would suggest that the hypergastrinemia associated with uremia may in fact be partially due to reduced acid production (9, 10). Since the kidney plays a major role in the catabolism and excretion of gastrin, especially the G34 moiety (12, 13) , the renal failure itself could contribute to the rise in the serum gastrin. Interestingly, many patients with elevated gastrin levels have normal acid secretion, suggesting inactive or partially active hormone or parietal cell resistance, which have both been described. Taylor et al. (11) has shown the poorly active G34 to be the major component of circulating gastrin in chronic renal failure. In contrast, the concentration of G17, which is six times more potent than G34, is not increased. In addition, resistance to pentagastrin stimulation has been reported in patients with chronic renal failure in the absence of atrophic gastritis, (8, 9) suggesting an impaired parietal cell response. Thus evidently several factors are operative in the genesis of the abnormal gastric acid secretion in chronic renal failure.
Abnormalities of gastroduodenal morphology are . also common. Endoscopic studies in unselected hemodialysis patients have shown gastroduodenitis to be the most common lesion. As many as 75% of patients have either hemorrhagic gastritis, duodenitis, or gastric metaplasia (4, 10, 14-17). The high prevalence of these lesions despite a low incidence of gastric acid overproduction suggests impaired mucosal defence mechanisms. This may be due to the elevated urea concentration, which can promote back diffusion of H+ across the mucosal barrier, or to the bilary reflux commonly found in this population (18) . Helicobacter (previously Campylobacter) pylori has been recently reported to cause duodenitis and ulceration in areas of gastric metaplasia in the general population. According to a recent report the incidence of infection with this organism was not particularly increased in end-stage renal disease (17) . Helicobacter does not appear to be a major cause of gastroduodenal abnormalities in uremia, yet further Pahl and Vaziri studies are required to clarify this issue. A number of recent studies have revealed a high incidence of atrophic gastritis in the absence of detectable parietal cell antibodies in dialysis patients (4, 9, 16) but the cause and mechanism of this disorder is unclear.
Although initial reports suggested an increase in peptic ulcers in end stange renal disease (2, 3) recent prospective studies have failed to confirm this (9, 10, 16, 19) . Instead, as discussed previously, gastritis and doudenitis commonly occur in both asymptomatic and symptomatic patients.
Upper gastrointestinal bleeding is reported to be the cause of death in 3-7% of patients with chronic renal failure (21) . Hemorrhagic gastritis and duodenitis are the most common causes of bleeding. This is followed by peptic ulcer disease, present in about 30% of such cases. In a study of hemodialysis patients with upper gastrointestinal bleeding, Boyle et aI., (22) found the causes to be no different from those in the general population. However they noted that the dialysis patients had longer hospital stays, required more transfusions, and had a higher incidence of rebleeding. They noted a significant association with the use of ulcerogenic drugs in the dialysis patients.
It is of interest that angiodysplasia is quite common in dialysis patients. According to some Authors, it may be the source of bleeding in as many as 32% of those presenting with upper gastrointestinal hemorrhage (23, 24) . The reason for this is unknown. Possibly chronic engorgement of submucosal veins from chronic hypervolemia in the presence of dilated pre-capillary sphincters from either hyperkalemia or hypergastrinemia may be involved (23) . Reactive hyperemia from low flow states caused by hypotensive episodes during dialysis could aggravate the situation. Recently a high incidence of skin telangiectasias has been reported in aluminum factory workers (25) . This observation is intriguing, given the heavy use of aluminum containing phosphate binders and the high incidence of angiodysplasias in dialysis patients.
In summary, patients with chronic renal failure frequently have abnormal gastric acid production, impaired parietal cell function, and abnormal gastric mucosal defence mechanisms. The incidence of gastroduodenitis and angiodysplasia is greatly increased; that of peptic ulcer disease is not. Upper gastrointestinal bleeding remains a major cause of morbidity and mortality. 
